Ernexa Therapeutics announced highly encouraging results from three core Investigational New Drug (IND)-enabling safety studies of ERNA-101, its lead synthetic, allogeneic induced mesenchymal stromal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results